Last updated on July 2017

TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)


Brief description of study

This study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of single-dose TD-3504 and single dose 15N2-tofacitinib in healthy subjects and subjects with UC. The relative bioavailability of tofacitinib released from TD-3504 compared to co-administered oral heavy-labeled tofacitinib (15N2-tofacitinib) will also be evaluated.

Clinical Study Identifier: NCT03103412

Find a site near you

Start Over